Background

Dr. Clifford J. Woolf, Ph.D. is a Professor of Neurology and Neurobiology at Harvard Medical School. His research focuses on the study of the development of somatosensory circuits, pain and regeneration. He served as an Advisor of PureTech Ventures. Dr. Woolf moved to England in 1978, where he worked at University College London for close to 20 years, latterly as a Professor of Neurobiology. In 1997 Dr. Woolf moved to Boston and established the Neural Plasticity Research ... Group based in the Department of Anesthesia and Critical Care at the Massachusetts General Hospital and which is a part of the Neuroscience Program at Harvard Medical School. Dr. Woolf served as a Clinical Advisor of Ionix Pharmaceuticals. Dr. Woolf serves as Director of the F.M. Kirby Neurobiology Center at Children’s Hospital Boston. Dr. Woolf is the first incumbent of the Richard Kitz Chair of Anesthesia Research at Harvard Medical School and Massachusetts General Hospital. He is a Founding Scientific Advisory Board Chairman of Solace Pharmaceuticals Dr. Woolf is the founding SAB Chairman of Solace Pharmaceuticals. He serves as Member of Scientific Advisory Board at Envoy Therapeutics, Inc. Dr. Woolf is a Professor of Neurology and Neurobiology at Harvard Medical School, where his research focuses on the study of the development of somatosensory circuits, pain and regeneration. He has authored over 250 scientific papers and is an inventor on nearly 50 patents. Dr. Woolf’s research has led to numerous scientific breakthroughs, including the identification of the role of “central sensitization” in inflammatory and neuropathic pain. Dr. Woolf holds M.B., Ch.B., M.D. and a Ph.D. degree from the University of the Witwatersrand in Johannesburg South Africa.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.